The Independent’s journalism is supported by our readers. When you purchase through links on our site, we may earn commission.

Contraceptive patch worn for seconds could prevent pregnancy for six months

It would be the first long-acting contraceptive to not be administered by a health professional

Sexual health charity explains how the contraceptive patch works

A contraceptive patch that only needs to be applied to the skin for a matter of seconds could soon be available to women.

Scientists have been experimenting with the patch which releases levonorgestrel - a synthetic form of progesterone that’s already used in the morning after pill - into the skin via microscopic, biodegradable needles.

Like other long-acting contraceptive techniques, the microneedle contraceptive patch will disrupt the menstrual cycles of women using it.

Speaking to The Independent, lead author Dr Mark Prausnitz, of Georgia Tech in Atlanta said: “Levonorgestrel has been widely used as a contraceptive hormone for years in contraceptive implants and IUDs and it has an excellent safety record.

"A common side effect is irregular menstrual bleeding.”

The needles are said to be pain-free and made of the same material as dissolvable stitches used in surgery.

“The concentration levels of the drug are higher than that known to cause contraception in humans," Prausnitz said.

“Our goal is for women to be able to self-administer long-acting contraceptives with the microneedle patch that would be applied to the skin for five seconds just once a month.”

Originally designed for use in areas of the world with limited access to health care, scientists hope the microneedle contraceptive will provide a new family planning alternative to a broader population, potentially proving more popular than the pill or coil.

Once clinical tests have been completed on minimising skin irritations and on a larger patch that has been developed for human use, it is hoped the patch could provide contraception for up to six months.

The patch will need to be worn for a matter of seconds to work

If approved, the patch would be the first long-acting contraceptive to not involve an injection given by a doctor or health professional.

However, because the patch has only been tested on mice so far, scientists said more clinical trials are needed to determine the effect of the contraceptive microneedle on humans.

“We do not yet know how the contraceptive microneedle patches would work in humans,” Prausnitz said.

“Because we are using a well-established contraceptive hormone, we are optimistic that the patch will be an effective contraceptive.”

The research was reported 14 January in the journal Nature Biomedical Engineering.

Support free-thinking journalism and attend Independent events

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in